menu
    • menu

    Company profile for Xilio Therapeutics

    Pfanstiehl, a global leader in the manufacture of cGMP high purity, low endotoxin, low metals (HPLE-LM)TM injectable grade excipients.

    Virtual Booth

    Contact Supplier

    Global Pharma Healthcare: Setting the global benchmark in quality, innovation, and care

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Phyton is a World Leader in Plant Cell Fermentation Technology and Commercial Manufacturing.

    Virtual Booth

    Contact Supplier

    Farmak works in the development, production and marketing of APIs, Intermediates & Specialties// FDA inspected.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engine...
    Xilio is a Waltham, Massachusetts-based biopharmaceutical company focused on defeating cancer. The company’s proprietary technology enables the explosion of therapeutic activity specifically within the tumor while reducing toxicity throughout the body – a nod to the company name, Xilio, derived from the Latin term, Ex Nihilo, meaning creation or big-bang. Xilio is applying its technology to build a broad pipeline of engineered antibodies, cytokines and chemokines as potential new options for people living with cancer. To learn more, please visit www.xiliotx.com.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Xilio TherapeuticsUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    828 Winter St, Waltham, Massachusetts 02451
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.xiliotx.com/index.html
    Linkedin
    Linkedin
    https://www.linkedin.com/company/xilio-tx/
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Tides Asia

    Tides Asia

    Not Confirmed

    envelop Contact Supplier

    Tides Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Xilio Therapeutics Reveals Pipeline Progress & Q3 2025 Result
    Xilio Therapeutics Reveals Pipeline Progress & Q3 2025 Result

    13 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/13/3187190/0/en/Xilio-Therapeutics-Announces-Pipeline-and-Business-Updates-and-Third-Quarter-2025-Financial-Results.html

    GLOBENEWSWIRE
    13 Nov 2025
    Share Share
    Xilio Reports Late-Breaking Ph2 Vilastobart Data In MSS mCRC
    Xilio Reports Late-Breaking Ph2 Vilastobart Data In MSS mCRC

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183723/0/en/Xilio-Therapeutics-Announces-Late-Breaking-Phase-2-Data-for-Vilastobart-in-Patients-with-MSS-mCRC-and-High-Plasma-Tumor-Mutational-Burden-at-Society-for-Immunotherapy-of-Cancer-SIT.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Xilio Highlights Differentiated Masked Immunotherapy Portfolio
    Xilio Highlights Differentiated Masked Immunotherapy Portfolio

    07 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/07/3183720/0/en/Xilio-Therapeutics-Highlights-Portfolio-of-Differentiated-Masked-Immunotherapies-at-Society-for-Immunotherapy-of-Cancer-SITC-40th-Annual-Meeting.html

    GLOBENEWSWIRE
    07 Nov 2025
    Share Share
    Xilio Therapeutics Reveals Inducement Grants Per Nasdaq LR
    Xilio Therapeutics Reveals Inducement Grants Per Nasdaq LR

    03 Nov 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/11/03/3179852/0/en/Xilio-Therapeutics-Announces-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html

    GLOBENEWSWIRE
    03 Nov 2025
    Share Share
    Xilio Therapeutics To Showcase Vilastobart Phase 2 Data at SITC
    Xilio Therapeutics To Showcase Vilastobart Phase 2 Data at SITC

    30 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/30/3177502/0/en/Xilio-Therapeutics-to-Present-Phase-2-Data-for-Vilastobart-Highlighting-Response-Rate-in-Patients-with-MSS-mCRC-and-High-Plasma-Tumor-Mutational-Burden-as-a-Late-Breaking-Presentat.html

    GLOBENEWSWIRE
    30 Oct 2025
    Share Share
    Xilio Therapeutics To Present At (SITC) 40Th Annual Meeting
    Xilio Therapeutics To Present At (SITC) 40Th Annual Meeting

    03 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/03/3160966/0/en/Xilio-Therapeutics-Announces-Upcoming-Presentations-at-the-Society-for-Immunotherapy-of-Cancer-SITC-40th-Annual-Meeting.html

    GLOBENEWSWIRE
    03 Oct 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search